Health Care [ 5/12 ] | Pharmaceuticals [ 13/73 ]
NASDAQ | Common Stock
Gelteq Limited focuses on developing, testing, and commercializing white label gel-based delivery solutions for humans and animals in Asia-Pacific Region.
It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products.
The company has a strategic alliance with IDT Australia Limited for the development and scale up of its gel-based products across diverse global pharmaceutical, nutraceutical and animal health markets.
Gelteq Limited was incorporated in 2017 and is headquartered in Caulfield, Australia.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jun 30, 25 | -0.38 | - |
| Nov 15, 24 | -0.14 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | N/A Decreased by -100.00% | -1.13 M Increased by +8.37% | - - |
| Jun 30, 24 | 0.00 Decreased by N/A% | -1.13 M Decreased by -385.46% | Decreased by N/A% - |
| Mar 31, 24 | 0.00 - | -727.42 K - | Decreased by N/A% - |
| Jun 30, 23 | -1.00 - | -947.83 K - | Increased by +94.78 M% - |
| Jun 30, 22 | 147.54 K - | -1.24 M - | Decreased by -838.21% - |
| Jun 30, 21 | N/A - | -233.41 K - | - - |